US FDA gives final approval to Alembic Pharma’s Diclofenac Sodium Topical Solution
Diclofenac Sodium Topical Solution is indicated for the treatment of the pain of osteoarthritis of the knees
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
US FDA approval
US FDA approves JB Pharma’s generic Venlafaxine extended-release tablets
The product is based on Osmotic Controlled Release Oral Delivery System (OROS) technology, an advanced and precision controlled…
US FDA gives final approval to Alembic Pharma’s Nifedipine extended-release tablets
The tablets are indicated for the management of vasospastic angina, chronic stable angina (classical effort-associated angina) and…
US FDA gives final approval to Alembic Pharma’s Cyclophosphamide capsules
Cyclophosphamide capsules is an alkylating drug indicated for the treatment of malignant disease and minimal change nephrotic…
Lupin gets FDA nod to market generic antibiotic medicine in US
Doxycyline capsule is a generic equivalent of Galderma Laboratories' Oracea capsules
US FDA gives tentative approval to Lupin for Drospirenone tablets
Drospirenone tablets had estimated annual sales of $141 million in the US
US FDA approves Ketorolac Tromethamine injection by Alembic Pharma
This is the second injectable product approval from the company's General Sterile Facility (F-3) which was inspected in August,…
US FDA gives final approval to Glenmark Pharma’s Sodium Phenylbutyrate tablets
The tablets will be distributed in the US by Glenmark Pharma Inc., USA
US FDA gives final approval for Mesalamine extended-release capsules
Mesalamine extended-release capsules are indicated for the maintenance of remission of ulcerative colitis in adults.
US FDA gives final approval to Zydus’s Acetaminophen injection
Acetaminophen injection is indicated to relieve mild-to-moderate pain, and to reduce fever